September 17, 2014 4:18 PM ET

Pharmaceuticals

Company Overview of Endo Pharmaceuticals Solutions Inc.

Executive Profile

David P. Holveck

Former Chief Executive Officer, President and Director, Endo International plc
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 11 different industries.

See Board Relationships
69$319,435
As of Fiscal Year 2013

Background

Mr. David P. Holveck, known as Dave, serves as the Member of Life Sciences Advisory Board at Safeguard Scientifics, Inc. He serves as a Director of Endo Pharmaceuticals Inc. Mr. Holveck has been a Director of Light Sciences Oncology Inc. since April 2008, Endo Pharmaceuticals Holdings Inc. since March 23, 2008, and Centocor Ortho Biotech, Inc. since 1994. He serves as a Director of CV Therapeutics and The Biotechnology Institute. He has been a Director of Penwest Pharmaceuticals ...

Corporate Headquarters

100 Endo Boulevard
Chadds Ford, Pennsylvania 19317

United States

Phone: 610-558-9800
Fax: 484-840-4287

Board Members Memberships

Director
Former Director
Director
1994-N/A
Director
2008-2013
Former Chief Executive Officer, President and Director
2008-2008
Former Director
2008-N/A
Former Director
2009-N/A
Chief Executive Officer, President and Director
2010-Present
Director
2010-Present
Director
2010-Present
Director

Education

BS
West Chester University of Pennsylvania

Other Affiliations

Annual Compensation

Salary$240,625
Total Annual Compensation$240,625

Stocks Options

All Other Compensation$78,810
Exercised Options$822,472
Exercised Options Value$12,329,846
Unexercisable Options$253,629
Unexercisable Options Value$8,961,558
Total Value of Options$21,291,404
Total Number of Options$1,076,101

Total Compensation

Total Annual Cash Compensation$319,435
Total Short Term Compensation$240,625
Other Long Term Compensation$78,810
Total Calculated Compensation$319,435
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Timothy M. Ring Chairman, Chief Executive Officer and Chairman of Executive Committee
CR Bard Inc.
$1.1M
Dow R. Wilson Chief Executive Officer, President and Director
Varian Medical Systems, Inc.
$892.0K
Michael A. Mussallem Chairman and Chief Executive Officer
Edwards Lifesciences Corp.
$879.8K
Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)Co-Chairman, Managing Director, Chief Executive Officer, Member of The Management Council, Member of Management Committee, Member of Investment Committee, Member of Corporate Social Responsibility Committee and Member of Stakeholders' Relationship Committee
Dr. Reddy's Laboratories Ltd.
$6.3M
Mark Christopher Trudeau Chief Executive Officer, President, Director and Member of Portfolio Committee
Mallinckrodt public limited company
$823.9K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Endo Pharmaceuticals Solutions Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.